Mississippi SB2025 aims to ensure parity in the prescription of pain medication by Medicaid and health insurance insurers.
Mississippi SB2025 mandates that the Division of Medicaid ensure nonopioid drugs are not disadvantaged on the preferred drug list. It requires health insurance insurers to develop plans for adequate coverage and access to pain management services, including nonopioid drugs and nonpharmacologic treatments. Insurers must also file these plans with the Department of Insurance for approval and distribute educational materials to providers and members annually. The act aims to prevent insurers from establishing more restrictive controls on nonopioid drugs compared to opioids.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.